Melanoma cell growth inhibition and melanocortin receptor downregulation induced by selective and non-selective retinoids

Melanoma Research

Volumn 8, Issue 2, 1998, Pages 113-122

  Siegrist, W ^a   Hintermann, E ^a   Roggo, C N ^a   Apfel, C M ^b   Klaus, M ^b   Eberle, A N ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Cell; Growth; Melanocortin; Melanoma; Receptor downregulation; Retinoids

Indexed keywords

MELANOCORTIN RECEPTOR; RETINOIC ACID RECEPTOR; RETINOID; RETINOID DERIVATIVE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL GROWTH; DOWN REGULATION; DRUG RECEPTOR BINDING; GROWTH INHIBITION; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031921120     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199804000-00003     Document Type: Article

References (34)

1. Sporn MB, Roberts AB, Goodman DS. The Retinoids: Biology, Chemistry, and Medicine, 2nd edn. New York: Raven Press, 1994.
2. Andersen B, Rosenfeld MG. Intracellular receptors. New wrinkles in retinoids. Nature 1995; 374: 118-119.
3. Yu VC, Delsert C, Andersen B, et al. RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 1991; 67: 1251-1266.
4. Amos B, Lotan R. Retinoid-sensitive cells and cell lines. Methods Enzymol 1990; 190: 217-225.
5. Warrell RP, Jr. Clinical and molecular aspects of retinoid therapy for acute promyelocytic leukemia. Int J Cancer 1997; 70: 496-497.
6. de Palo G, Formelli F. Risks and benefits of retinoids in the chemoprevention of cancer. Drug Saf 1995; 13: 245-256.
7. Triozzi PL, Walker MJ, Pellegrini AE, et al. Isotretinoin and recombinant interferon alfa-2a therapy of metastatic malignant melanoma. Cancer Invest 1996; 14: 293-298.
8. Fierlbeck G, Schreiner T, Rassner G. Combination of highly purified human leukocyte interferon alpha and 13-cis-retinoic acid for the treatment of metastatic melanoma. Cancer Immunol Immunother 1995; 40: 157-164.
9. Spanjaard RA, Ikeda M, Lee PJ, et al. Specific activation of retinoic acid receptors (RARs) and retinoid X receptors reveals a unique role for RARγ in induction of differentiation and apoptosis of S91 melanoma cells. J Biol Chem 1997; 272: 18990-18999.
10. Schadendorf D, Kern MA, Artuc M, et al. Treatment of melanoma cells with the synthetic retinoid CD 437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo. J Cell Biol 1996; 135: 1889-1898.
11. Clifford JL, Petkovich M, Chambon P, et al. Modulation by retinoids of mRNA levels for nuclear retinoic acid receptors in murine melanoma cells. Mol Endocrinol 1990; 4: 1546-1555.
12. Redfern CP, Daly AK, Latham JA, et al. The biological activity of retinoids in melanoma cells. Induction of expression of retinoic acid receptor-beta by retinoic acid in S91 melanoma cells. FEBS Lett 1990; 273: 19-22.
13. Xiao Y, Desai D, Quick TC, et al. Control of retinoic acid receptor expression in mouse melanoma cells by cyclic AMP. J Cell Physiol 1996; 167: 413-421.
14. Spanjaard RA, Sugawara A, Ikeda M, et al. Evidence that retinoid X receptors mediate retinoid-dependent transcriptional activation of the retinoic acid receptor beta gene in S91 melanoma cells. J Biol Chem 1995; 270: 17429-17436.
15. Ortonne JP. Retinoic acid and pigment cells: a review of in-vitro and in-vivo studies. Br J Dermatol 1992; 127 (suppl 41): 43-47.
16. Meyskens FL, Jr, Fuller BB. Characterization of the effects of different retinoids on the growth and differentiation of a human melanoma cell line and selected subclones. Cancer Res 1980; 40: 2194-2196.
17. Schadendorf D, Worm M, Jurgovsky K, et al. Effects of various synthetic retinoids on proliferation and immunophenotype of human melanoma cells in vitro. Recent Results Cancer Res 1995; 139: 183-193
18. Wang Z, Cao Y, D'Urso CM, et al. Differential susceptibility of cultured human melanoma cell lines to enhancement by retinoic acid of intercellular adhesion molecule 1 expression. Cancer Res 1992' 52: 4766-4772.
19. Niles RM, Loewy BP. Induction of protein kinase C in mouse melanoma cells by retinoic acid. Cancer Res 1989; 49: 4483-4487.
20. Chakraborty AK, Orlow SJ, Pawelek JM. Stimulation of the receptor for melanocyte-stimulating hormone by retinoic acid. FEBS Lett 1990; 276: 205-208.
21. Siegrist W, Stutz S, Eberle AN. Homologous and heterologous regulation of alpha-melanocyte-stimulating hormone receptors in human and mouse melanoma cell lines. Cancer Res 1994; 54: 2604-2610.
22. Chhajlani V, Wikberg JE. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett 1992; 309: 417-420.
23. Mountjoy KG, Robbins LS, Mortrud MT, et al. The cloning of a family of genes that encode the melanocortin receptors. Science 1992; 257: 1248-1251.
24. Eberle AN. The Melanotropins: Chemistry, Physiology and Mechanism of Action. Basel: Karger, 1988.
25. Apfel C, Bauer F, Crettaz M, et al. A retinoic acid receptor alpha antagonist selectively counteracts retinoic acid effects. Proc Natl Acad Sci USA 1992; 89: 7129-7133.
26. Apfel CM, Kamber M, Klaus M, et al. Enhancement of HL-60 differentiation by a new class of retinoids with selective activity on retinoid X receptor. J Biol Chem 1995; 270: 30765-30772.
27. Eberle AN, Venn VJ, Solca F, et al. Biologically active monoiodinated alpha-MSH derivatives for receptor binding studies using human melanoma cells. J Recept Res 1991; 11: 311-322.
28. Oliver MH, Harrison NK, Bishop JE, et al. A rapid and convenient assay for counting cells cultured in micro-well plates: application for assessment of growth factors. J Cell Sci 1989; 92: 513-518.
29. Siegrist W, Solca F, Stutz S, et al. Characterization of receptors for alpha-melanocyte-stimulating hormone on human melanoma cells. Cancer Res 1989; 49, 6352-6358.
30. Munson PJ, Rodbard D. LIGAND; a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980; 107: 220-239.
31. Siegrist W, Eberle AN. Melanocortins and their implication in melanoma. Trends Endocrinol Metab 1995; 6: 115-120.
32. Gruber JR, Ohno S, Niles RM. Increased expression of protein kinase C alpha plays a key role in retinoic acid-induced melanoma differentiation. J Biol Chem 1992; 267: 13356-13360.
33. Siegrist W, Sauter P, Eberle AN. A selective protein kinase C inhibitor (CGP 41251) positively and negatively modulates melanoma cell MSH receptors. J Recept Signal Transd Res 1995; 15: 283-296.
34. Chakraborty AK, Pawelek JM. Up-regulation of MSH receptors by MSH in Cloudman melanoma cells. Biochem Biophys Res Commun 1992; 188: 1325-1331.